ISOLF — Isodiol International Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $3.15m
- CA$22.25m
Annual balance sheet for Isodiol International, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2015 March 31st | 2016 March 31st | 2017 March 31st | 2018 March 31st | 2019 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.015 | 0.106 | 0.719 | 15.5 | 2.87 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.006 | 0.066 | 0.151 | 4.97 | 13.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 0.078 | 0.485 | 1.36 | 22.8 | 19.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | 0 | 0.059 | 1.06 | 1.62 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.078 | 0.485 | 2.28 | 54.5 | 23.6 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.416 | 1.23 | 0.375 | 6.7 | 11.5 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.416 | 1.23 | 0.375 | 6.7 | 16.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | -0.338 | -0.743 | 1.9 | 47.8 | 6.93 |
| Total Liabilities & Shareholders' Equity | 0.078 | 0.485 | 2.28 | 54.5 | 23.6 |
| Total Common Shares Outstanding |